AK

Amit Kumar

Active Director Director DIN 09552573
DIN 09552573 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Amit Kumar

Data last updated:

Amit Kumar is a Director at Bio Bit Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Bio Bit Pharmaceuticals Private Limited reported revenue of ₹69.1 Lakh (FY 2025).

DIN 09552573
Primary Designation Director
Industry Chemicals
First Appointment 29 Mar 2022
Oldest Company Age 4 yrs
Largest company Bio Bit Pharmaceuticals Private Limited · ₹69.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20222022₹69.1 Lakh (FY 2025)Active

Board colleagues of Amit Kumar

NameDINCompanyDesignation
Sunil Kumar02098914Bio Bit Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bio Bit Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amit Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Kumar

Amit Kumar currently holds 1 directorship: Bio Bit Pharmaceuticals Private Limited (Director, since 29 Mar 2022, revenue ₹69.1 Lakh (FY 2025)).

Amit Kumar was first appointed on 29 Mar 2022 as Director at Bio Bit Pharmaceuticals Private Limited.

The current boards of Amit Kumar's companies include Sunil Kumar (Bio Bit Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available